ID: ALA3827923

Max Phase: Preclinical

Molecular Formula: C19H18O3

Molecular Weight: 294.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc2c(cc1C(=O)c1ccccc1C(=O)O)CCCC2

Standard InChI:  InChI=1S/C19H18O3/c1-12-10-13-6-2-3-7-14(13)11-17(12)18(20)15-8-4-5-9-16(15)19(21)22/h4-5,8-11H,2-3,6-7H2,1H3,(H,21,22)

Standard InChI Key:  BKIOAOJEWJMUDA-UHFFFAOYSA-N

Associated Targets(non-human)

Botulinum neurotoxin type E 94 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.35Molecular Weight (Monoisotopic): 294.1256AlogP: 3.80#Rotatable Bonds: 3
Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.49CX Basic pKa: CX LogP: 5.06CX LogD: 1.68
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.88Np Likeness Score: -0.33

References

1. Kumar G, Agarwal R, Swaminathan S..  (2016)  Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model.,  24  (18): [PMID:27353886] [10.1016/j.bmc.2016.06.036]

Source